Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Pharmaceutical Research
|
August 12, 2006
Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA
Eva Bondesson, Thomas Bengtsson, Lars-Erik Nilsson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 28, 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis
Henrik Watz, Kathleen Rickard, Tara Rheault, et al.
Current Medical Research and Opinion
|
April 19, 2008
Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers
Gunnar Persson, Jaro Ankerst, Michael Gillen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value
Thomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Drug Design, Development and Therapy
|
February 25, 2015
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
Leif Bjermer, Piotr Kuna, Carin Jorup, et al.
Respiratory Medicine
|
March 15, 2005
Formoterol used as needed in patients with intermittent or mild persistent asthma
Alexandr Chuchalin, Milan Kasl, Thomas Bengtsson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 29, 2021
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
Gary T Ferguson, Edward M Kerwin, Tara Rheault, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 3, 2023
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
James F Donohue, Tara Rheault, Margot MacDonald-Berko, et al.
EJNMMI Research
|
February 3, 2012
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport
Simon-Peter Williams, Judith E Flores-Mercado, Ruediger E Port, et al.
Respiratory Research
|
February 12, 2020
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
Dave Singh, Fernando J Martinez, Henrik Watz, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Pharmaceutical Research
|
August 12, 2006
Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA
Eva Bondesson, Thomas Bengtsson, Lars-Erik Nilsson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 28, 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis
Henrik Watz, Kathleen Rickard, Tara Rheault, et al.
Current Medical Research and Opinion
|
April 19, 2008
Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers
Gunnar Persson, Jaro Ankerst, Michael Gillen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2012
18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value
Thomas Bengtsson, Rodney J Hicks, Amy Peterson, et al.
Drug Design, Development and Therapy
|
February 25, 2015
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
Leif Bjermer, Piotr Kuna, Carin Jorup, et al.
Respiratory Medicine
|
March 15, 2005
Formoterol used as needed in patients with intermittent or mild persistent asthma
Alexandr Chuchalin, Milan Kasl, Thomas Bengtsson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 29, 2021
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
Gary T Ferguson, Edward M Kerwin, Tara Rheault, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 3, 2023
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
James F Donohue, Tara Rheault, Margot MacDonald-Berko, et al.
EJNMMI Research
|
February 3, 2012
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport
Simon-Peter Williams, Judith E Flores-Mercado, Ruediger E Port, et al.
Respiratory Research
|
February 12, 2020
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
Dave Singh, Fernando J Martinez, Henrik Watz, et al.
Page
of 7